| Name | Title | Contact Details |
|---|
Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.
Our mission is simple: we are focused on changing the world for children with autism. Learn more about our ABA Services.
itsRX is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Exeter Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Corden Pharma Colorado is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.